Ascendo Biotechnology
Chemicals & Related Products · Taiwan · 11-50 Employees
View Company Info for Free
Overview
Headquarters
7f No. 3 Aly. 30 Ln. 358 Ruiguang Rd Rm ...Website
www.ascendobiotech.comRevenue
<$5 MillionIndustry
About Ascendo Biotechnology
Ascendo Biotechnology is a biopharmaceutical company focused on developing novel cancer immunotherapies and functional cures for chronic viral infections by targeting the innate immune system. Their lead asset, ASD141, is currently in Phase I clinical trials aimed at treating solid tumors that are resistant to existing therapies. The company aims to transform treatment outcomes for patients who have exhausted existing options by leveraging the untapped potential of the innate immune system. Ascendo's innovative approach includes a first-in-class innate immune checkpoint platform and a diverse pipeline of clinical and preclinical programs.Explore more
Ascendo Biotechnology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Ascendo Biotechnology Tech Stack
A closer look at the technologies used by Ascendo Biotechnology
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Ascendo Biotechnology
Sign Up For FreeTo access detailed company insights
Ascendo Biotechnology is a biopharmaceutical company focused on developing novel cancer immunotherapies and functional cures for chronic viral infections by targeting the innate immune system. Their lead asset, ASD141, is currently in Phase I clinical trials aimed at treating solid tumors that are resistant to existing therapies. The company aims t... Read More
